Formula for treating and preventing arthritis, synovitis and other orthopaedic diseases and complicating diseases

A technology for arthritis and synovitis, applied in the field of formulations for the treatment and prevention of arthritis and synovitis and other orthopedic diseases and concurrent diseases

Inactive Publication Date: 2009-12-23
陈霞
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Toxicology research experiments have proved that in acute toxicity experiments, we increased the dosage to the most concentrated level (400 times that of human consumption) and still did not measure the lethal dose (LD50), which proved to be extremely safe; There is no report on the interaction between α-pandrostin and other drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0009] The invention covers a variety of formulations in the same proportion, which are used to treat diseases such as arthritis and synovitis. The main active ingredient used is alpha-mangostin, and its content ranges from 0.1% to 99.9%, and it is combined with appropriate fillers to make a new product with anti-inflammatory and analgesic properties. The main diseases to be treated and prevented are: various types of arthritis, synovitis, hyperosteogeny, rheumatism and rheumatoid arthritis, ankylosing spondylitis, osteoporosis, spinal stenosis, femoral head necrosis, bone injury, bone tumor and other diseases. The product can be made into 20mg-10g tablets, pills, capsule powders or other dosage forms for convenient consumption.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a formula for treating and preventing arthritis, synovitis and other orthopaedic diseases and complicating diseases and discloses a main compound extracted from mangosteen:Garcinia mangostana. In the main compound, alpha-mangostin serving as a main ingredient is used in combination with various common filters in pharmaceuticals industry to prepare various proper formulations including tablets, capsules, powders, suppositories and the like for oral or external use for treating and preventing arthritis diseases such as rheumatoid arthritis, chronic infectious arthritis, post-traumatic arthritis, osteoarthritis and purulent arthritis as well as complicating diseases of the arthritis diseases such as inflammations of finger joints, metacarpophalangeal joints, wrist joints, elbow joints, shoulder joints, knee joints, spondyl joints, ankle joints, metatarsophalangeal joints and other joints. The alpha-mangostin content of the product of the invention is between 0.1 and 99.9 percent. The product manufactured by the formula can relieve the various inflammations and has certain analgesic effect. The product can be used alone or in combination with other substances.

Description

Technical field: [0001] Arthritis and synovitis are common and multiple chronic diseases. There are many reasons for their pathogenesis, such as: immune or allergic reaction, infection, metabolic disorder, bone trauma, muscle atrophy, accumulation of old damage, bone hyperplasia, genetic Wait. At present, physiotherapy, hormonal drugs, traditional Chinese medicine, non-steroidal anti-inflammatory drugs, glucosamine and chondroitin sulfate, surgery, etc. are mostly used in the treatment of arthritis and synovitis. [0002] The invention innovates a new effective formula for treating arthritis and synovitis without causing side effects on human body, and provides a safe and effective health-promoting product for patients. Background of the invention: [0003] The present invention contains mangosteen (mangosteen: Garcinia Mangostana) extract, its main active ingredient is alpha-mangostin (alpha-mangostin), its content ranges from 0.1% to 99.9% of the dose as the main active i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61K9/48A61K9/20A61P29/00A61P19/08A61P19/02A61P19/10A61P35/00A61K131/00A61K129/00
Inventor 陈霞
Owner 陈霞
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap